<a href="https://twitter.com/mjburnsy">Matt Burns</a> spoke to <a href="https://twitter.com/jamespeyer">James Peyer</a>, the co-founder of <a href="https://twitter.com/cambrianbio">Cambrian BioPharma</a>, and <a href="https://twitter.com/futuresaenko">Maryanna Saenko</a>, co-founder and partner at <a href="https://twitter.com/VenturesVc">Future Ventures</a>. Cambrian BioPharma is a new pharmaceutical startup with a revolutionary approach to developing and managing drug development age-related diseases. 
What we&#8217;re most interested in, though, is how Cambrian’s executive team attracts and retains top talent. (Spoiler: They give them an oversized amount of equity compared to traditional pharmaceutical companies.)
James and Maryanna spoke to us about:
<ul>
<li>Developing therapeutics for anti-aging in a way that works with the existing regulatory structure</li>
<li>How James and Maryanna solve the &#8216;venture capital math problem&#8217; </li>
<li>But first we spoke on moving research from academia to the real world and fighting misconception and buzzwords around longevity biotech</li>
</ul>
We closed out the show with a new batch of founders for Pitch Practice. And as always, if you want to check out the full video of today&#8217;s conversation, head to our <a href="https://www.youtube.com/playlist?list=PLHRxVckaE8daUi7H3bRpmzI1WtGHKXq6r">YouTube</a> channel and stay tuned for more TechCrunch Live!
The TechCrunch Live Podcast drops at 6:00 a.m. PT every Monday, so subscribe to us on <a href="https://podcasts.apple.com/podcast/id1620384487" target="_blank" rel="noopener">Apple Podcasts</a>,<a href="https://pod.link/TCLpodcast.overcast" target="_blank" rel="noopener"> Overcast</a>,<a href="https://open.spotify.com/show/5O7t0TgE8ygyLVvSvPQb8K" target="_blank" rel="noopener">Spotify</a> and all the casts.

How Cambrian BioPharma is reinventing drug - and drug company -  development

Future Ventures

Matt Burns spoke to James Peyer, the co-founder of Cambrian BioPharma, and Maryanna Saenko, co-founder and partner at Future Ventures. Cambrian BioPharma is a new pharmaceutical startup with a revolutionary approach to developing and managing drug development age-related diseases.  What we&#8217;re most interested in, though, is how Cambrian’s executive team attracts and retains top talent. [&hellip;]

The TechCrunch Live Podcast Episode #32

How Cambrian BioPharma is reinventing drug - and drug company - development